Complement and Cardiovascular Disease--The Missing Link in Haemodialysis Patients

Area of Science:

• Nephrology
• Immunology
• Cardiovascular Medicine

Background:

• Patients on hemodialysis (HD) exhibit high rates of cardiovascular (CV) disease and complement system activation.
• The link between complement activation and CV disease in HD patients is understudied.
• This study investigates the association between complement levels and CV events/mortality in HD patients.

Purpose of the Study:

• To evaluate the relationship between baseline complement levels and subsequent CV events and mortality in HD patients.
• To assess the effect of hemodialysis with a vitamin E (VE)-coated membrane on complement levels.
• To explore the prognostic utility of complement components in HD patients.

Main Methods:

• A randomized controlled trial involving 260 HD patients.
• Patients were assigned to dialysis with either a VE-coated or non-VE coated membrane for 12 months.
• Complement levels (C3, factor D, factor H, SC5b-9) and clinical outcomes (CV events, mortality) were monitored.

Main Results:

• Higher baseline C3 levels correlated with increased risk of subsequent CV events.
• Intermediate SC5b-9 levels were associated with significantly lower CV event rates and mortality.
• VE-coated membranes did not affect measured complement levels or clinical outcomes.

Conclusions:

• C3 and SC5b-9 levels may serve as prognostic markers for CV events and mortality in HD patients.
• Further research is needed to confirm the prognostic value of these complement components.
• VE-bonded polysulfone membranes did not alter alternative complement pathway components in prevalent HD patients over 12 months.